alzheimer’s-‘resilience-signature’-predicts-who-will-develop-dementia-–-and-how-fast

Investigators from the Knight Initiative have identified a biomarker in cerebrospinal fluid that might assist in predicting the advancement of Alzheimer’s and enhance clinical studies.


Leave a Reply

Your email address will not be published. Required fields are marked *

Share This